American Board of Medical Specialties

As mandated by the American Board of Medical Specialties, the Board has developed a Maintenance of Certification (MOC) program that includes four components:

1. Professional Standing;
2. Self-Assessment and CME;
3. Cognitive Expertise;
4. Performance in Practice.

As of October 1, 1994, all individuals achieving Board certification by the ABPN are issued 10-year, time-limited certificates. Certificates issued in the subspecialties of addiction psychiatry, clinical neurophysiology, epilepsy, forensic psychiatry, geriatric psychiatry, hospice and palliative medicine, neurodevelopmental disabilities, neuromuscular medicine, pain medicine, psychosomatic medicine, sleep medicine, and vascular neurology, including those issued prior to October 1, 1994, are 10-year, time-limited certificates. Time-limited certificates for child and adolescent psychiatry began in 1995.

Diplomates who are not recertified before their certificates expire are no longer Board certified in that area of certification. Once a former diplomate completes all MOC requirements and passes the MOC examination, however, he or she will regain certification status. 

Diplomates of the ABPN are required to maintain records of their self-assessment (SA) activities, Continuing Medical Education (CME) credits, and Performance in Practice (PIP) Units. Diplomates must provide their signature attesting to completion of these activities (as determined by the phase-in schedule) on their applications for the MOC examinations. When the MOC Program is fully operational, attestation to all components will be required on applications for the MOC examinations.

Frequently Asked Questions about MOC

Association of University Professors of Neurology

The AUPN partners with the ANA to present Career Development courses each year at the ANA's Annual Meeting. The AUPN provides career development courses the Chairs of Neurology, and holds its Annual Meeting in conjunction with the ANA's Annual Meeting.

Child Neurology Society

The Annals of Neurology, the official journal of the American Neurological Association and the Child Neurology Society. The Annals is ranked #2 in Clinical Neurology and #9 in Neurosciences. The Annals of Neurology’s Impact Factor is 11.089.

American Society for Experimental NeuroTherapeutics

ASENT and the ANA are collaborating to advance the development of new therapies for neurological disorders, by bringing together key leaders from the academic neurology community, industry and government to explore the challenges associated with CNS therapy development.